Torrent Pharmaceuticals Limited (BOM:500420)

Market Cap	1.94T +53.7%
Revenue (ttm)	157.23B +32.8%
Net Income	21.81B +8.9%
EPS	62.51 +5.7%
Shares Out	380.37M
PE Ratio	81.64
Forward PE	69.69
Dividend	38.00 (0.74%)
Ex-Dividend Date	May 29, 2026

Volume	471,150
Open	4,969.10
Previous Close	4,870.65
Day's Range	4,894.90 - 5,139.30
52-Week Range	3,480.00 - 5,139.30
Beta	0.14
Analysts	Buy
Price Target	5,345.57 (+4.76%)
Earnings Date	Jul 30, 2026

About Torrent Pharmaceuticals

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, CNS, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, dermatology, pulmonology, pediatric treatments, nutritional, pain management, anti-infective, and miscellaneous...

• Industry: Pharmaceutical Preparations
• Founded: 1959
• Employees: 18,258
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 500420

Financial Performance

In fiscal year 2026, Torrent Pharmaceuticals's revenue was 139.80 billion, an increase of 21.39% compared to the previous year's 115.16 billion. Earnings were 21.63 billion, an increase of 13.19%.

Analyst Summary

According to 28 analysts, the average rating for 500420 stock is "Buy." The 12-month stock price target is ₹5,346, which is an increase of 4.76% from the latest price.

Price Target

₹5,346

(4.76% upside)

Analyst Consensus: Buy

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 2, 2026

Data Sources Report a data error